{"schema_version":"1","generated_at":"2026-11-20T15:40:15.148Z","data_as_of":null,"url":"https://www.findmykol.com/kol/alireza-nami","json_url":"https://www.findmykol.com/kol/alireza-nami/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"alireza-nami","name":"Alireza Nami","credential":"MD","specialty":"Rheumatology","specialty_raw":"Rheumatology","therapeutic_area":"Rheumatology/Immunology","therapeutic_areas":["Rheumatology/Immunology"],"city":"Charlotte","state":"NC","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"on_file":["npi","openalex"],"values":"Shown on the profile page to a signed-in account."},"summary":"Alireza Nami is a Rheumatology/Immunology physician. OpenAlex indexes 6 publications with 1,073 citations (h-index 5).","overview":null,"focus":{"indications":[],"research_topics":["Rheumatology/Immunology"]},"scholarship":{"works_count":6,"cited_by_count":1073,"h_index":5,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":25,"program_years":{"first":2021,"last":null},"rows_total":97,"shown":3,"withheld":94,"rows":[{"payer":"Janssen","program_year":2025,"amount_usd":156697,"payment_count":15},{"payer":"AbbVie","program_year":2025,"amount_usd":119104.41,"payment_count":24},{"payer":"AstraZeneca","program_year":2025,"amount_usd":100711.45,"payment_count":1}],"source":"payments"},"prescribing":{"data_year":2023,"areas_total":12,"areas_shown":3,"areas":[{"area":"Musculoskeletal","share_pct":49.3,"classes_total":9,"classes":[{"class":"RANK Ligand Inhibitor","setting":"mixed","share_pct":36.2,"drugs":[{"name":"Denosumab","share_pct":98.6},{"name":"Prolia","share_pct":1.4}],"max_beneficiaries":32},{"class":"Central alpha-2 Adrenergic Agonist","setting":"prescribed","share_pct":5,"drugs":[{"name":"Tizanidine Hcl","share_pct":100}],"max_beneficiaries":106}]},{"area":"Nervous system","share_pct":19.6,"classes_total":12,"classes":[{"class":"Gabapentinoids","setting":"prescribed","share_pct":7.4,"drugs":[{"name":"Gabapentin","share_pct":69.8},{"name":"Pregabalin","share_pct":30.2}],"max_beneficiaries":113},{"class":"SNRI","setting":"prescribed","share_pct":6.3,"drugs":[{"name":"Duloxetine Hcl","share_pct":100}],"max_beneficiaries":146}]},{"area":"Cancer & immunology","share_pct":13.5,"classes_total":7,"classes":[{"class":"Folate Analog Metabolic Inhibitor","setting":"mixed","share_pct":8.4,"drugs":[{"name":"Methotrexate sodium","share_pct":47.2},{"name":"Methotrexate","share_pct":44.7},{"name":"Rasuvo","share_pct":3.2},{"name":"Otrexup","share_pct":2.8},{"name":"Methotrexate Sodium","share_pct":2.1}],"max_beneficiaries":null},{"class":"Antirheumatic Agent","setting":"prescribed","share_pct":1.3,"drugs":[{"name":"Leflunomide","share_pct":100}],"max_beneficiaries":30}]}],"care_setting":{"dominant":"office","data_year":2023,"office_pct":100,"facility_pct":0},"source":"medicare"},"similar":[{"name":"David Felson","slug":"david-felson","institution":"Boston University","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/david-felson","json_url":"https://www.findmykol.com/kol/david-felson/profile.json"},{"name":"Marc Hochberg","slug":"marc-hochberg","institution":"University of Maryland School of Medicine","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/marc-hochberg","json_url":"https://www.findmykol.com/kol/marc-hochberg/profile.json"},{"name":"Philip Mease","slug":"philip-mease","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/philip-mease","json_url":"https://www.findmykol.com/kol/philip-mease/profile.json"},{"name":"Michelle Petri","slug":"michelle-petri","institution":"Johns Hopkins University School of Medicine","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/michelle-petri","json_url":"https://www.findmykol.com/kol/michelle-petri/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":94}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2023}},"methodology_url":"https://www.findmykol.com/about#methodology"}